Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olive Oil and Omega 3 Local Treatment in Stasis Dermatitis
NCT00421161Phase 2Unknown
- Sponsor
- Shamir Medical Center
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of olive oil and MAT9001 in Stasis Dermatitis (SD) (2 arms), sponsored by Shamir Medical Center. Primary endpoint: Improvement in subjective and objective skin changes. Status: unknown.
02
Drugs
olive oilMAT9001
03
Conditions
Stasis Dermatitis (SD)
Beyond the preview
Go deeper on NCT00421161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00421161.